Skip to content
Screener

Arrowhead Research ARWR Noncontrolling interests in subsidiaries

Noncontrolling interests in subsidiaries at other companies

BridgeBio Pharma logo
BridgeBio PharmaBBIO
$10.34M+4.6%
RFL
Rafael Holdings, Inc.RFL
$5.42M+37.5%

Other financials

Income statement

See full
Revenue$73.7M-86.4%
Operating income-$141.3M-137%
Net income-$132.7M-136%
EPS (diluted)-$0.93-134%

Balance sheet

See full
Cash & equivalents$188.5M+1.5%
Total debt$107.9M-5.6%
Total equity$614.0M-10.1%
Total assets$2.3B+44.2%

Cash flow

See full
Operating cash flow$84.4M-81.6%
CapEx$2.6M-51.6%
Free cash flow$81.9M-82.0%

Valuation

See full
Market cap$12.38B+420%
Enterprise value$12.3B+421%
P/S19.9×+15.7×

Profitability

See full
Operating margin-35.7%+63.6pp
Net margin-48.4%+240pp
FCF margin1.8%+0.9pp

Returns & leverage

See full
Return on equity-46.4%+341pp
Debt / equity0.2×0.0×
Current ratio6.2×+1.1×

Where this comes from

Reported directly by Arrowhead Research in its filing.

Tagged under the XBRL concept us-gaap:MinorityInterest.

The source filing: Arrowhead Research’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:05 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q1 2026
Accession
0000879407-26-000047
Line itemMarch 31, 2026September 30, 2025
Additional paid-in capital2,395,2672,139,725
Accumulated other comprehensive income7426,443
Accumulated deficit(1,729,075)(1,627,154)
Treasury stock; at cost; 2,661 shares of common stock at March 31, 2026 and September 30, 2025(53,193)(53,193)
Stockholders’ equity613,977466,052
Noncontrolling interest(15,061)37,364
Total noncontrolling interest and stockholders’ equity598,916503,416
Total Liabilities, Noncontrolling Interest and Stockholders’ Equity$2,268,265$1,385,295

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Arrowhead Research's noncontrolling interests in subsidiaries?
Arrowhead Research (ARWR) reported noncontrolling interests in subsidiaries of -$15.06M in Q1 2026.
How has Arrowhead Research's noncontrolling interests in subsidiaries changed year-over-year?
Arrowhead Research's noncontrolling interests in subsidiaries decreased by 1766.0% year-over-year, from $904K to -$15.06M.
What does noncontrolling interests in subsidiaries mean?
This represents the portion of a subsidiary's net assets that is owned by outside shareholders rather than the parent company. It is reported within equity to show the total value of the subsidiary's assets and liabilities that are not attributable to the parent. It reflects the non-controlling stake in consolidated entities.

Ask your AI about Arrowhead Research's noncontrolling interests in subsidiaries.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude